Skip to main content
Smart Investors Daily
SD

NASDAQ · SDGR

Schrödinger, Inc.

Healthcare · Medical - Healthcare Information Services

$23.25

Up+$2.50 (+12.05%)

Updated Sep 16, 2026, 10:05 AM

SID Score

6.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.34B
P/E ratio
-7.34
Dividend yield
0.00%
52-week range
$10.95 – $21.40
Volume
3.8M
Avg. volume
1.08M

Price performance

SDGR price history

1M range · 0 trading sessions · Daily adjusted prices

SDGR does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest SDGR news

The latest Smart Investors Daily articles mentioning SDGR.

SDGR research

Overview

Company profile and research snapshot.

Company profile

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$19.00
Implied upside
Analysts
15
SDGR recent ratings
DateFirmRatingTarget
May 14, 2026Morgan StanleyEqual-Weight
Mar 17, 2026UBSNeutral
Jan 8, 2026KeybancOverweight
Jan 8, 2026TD CowenBuy
Jan 7, 2026UBSNeutral
Open full forecast

News briefing

Data unavailable

Market data is busy. Please try again shortly.

AI research layers

Interpretive context generated from the platform’s current data sources.

Data unavailable

Market data is busy. Please try again shortly.